Lucid Diagnostics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LUCD, updated each market day.
LUCD AI Sentiment
AI predicts Lucid Diagnostics Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Lucid Diagnostics Inc. Common Stock
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Sector
Exchange
Market Cap
$149,016,388
Cap Tier
Employees
82
Headquarters
NEW YORK, NY
Listed Since
Oct. 14, 2021
Website
LUCD Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LUCD Volatility
Lucid Diagnostics Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
